Factors related with COVID-19 vaccination willingness among outpatients in China

Author:

Zhang Di1,Cui Qi2,Xu Junyi3,Cai Jian4,Lu Xiaoping5,Yang Yinguang45

Affiliation:

1. School of Medicine, Jiangsu University, Zhenjiang, P. R. China

2. School of Public Health, China Medical University, Shenyang, P. R. China

3. Demonstration Ward of General Practitioners, Zhenjiang First People's Hospital, Zhenjiang, P. R. China

4. Hospital Branch, Zhenjiang First People's Hospital, Zhenjiang, P. R. China

5. Community Health Service Center of Dagang Street, Zhenjiang, P. R. China

Funder

Ministry of Education, Youth and Science

Medical education project of Chinese Medical Association and Chinese Higher Education Association

Top-quality project of social science application research in Jiangsu Provinc

Project of Research on Education Informatization of Jiangsu Province of China

Project of the 13th Five-Year Plan for Education Science of Jiangsu Province of China

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference33 articles.

1. Epidemic Update and Risk Assessment of 2019 Novel Coronavirus — China, January 28, 2020

2. Worder Health Organization(WHO). DRAFT landscape of COVID-19 candidate vaccines-30. 2020 Apr. [cited 2020 May 5]. https://www.who.int/whodocuments-detail/draft-landscape-of-COVID-19-candidate-vaccines.

3. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China

4. Worder Health Organization(WHO). World Health Assembly to focus on ending COVID-19 pandemic and preparing for next one 2021. [cited 2021 May 19]. https://www.who.int/news/item/19-05-2021-world-health-assembly-to-focus-on-ending-covid-19-pandemic-and-preparing-for-next-one.

5. National Health Commission of the People’s Republic of China. The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on June 2 [cited 2021 Jun 3]. http://www.nhc.gov.cn/xcs/yqfkdt/202106/d0052d72bf1b433784dfa76bf1cad3db.shtml.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3